ARGEN-X
To this end, arGEN-X has invented and developed a breakthrough discovery platform setting the new standard for antibody lead choice in the discovery of human antibody therapeutics. Fuelled by the best possible natural immune responses available, our Simple Antibodyâ„¢ platform leapfrogs existing platforms in what is probably the most critical aspect of drug discovery and development: lead choice.
ARGEN-X
Industry:
Biotechnology Clinical Trials Therapeutics
Founded:
2008-01-01
Address:
Rotterdam, Zuid-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.argenx.com
Total Employee:
501+
Status:
Active
Contact:
+320477772944
Total Funding:
1.95 B USD
Technology used in webpage:
IPhone / Mobile Compatible SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS ASP.NET IIS Sectigo SSL Sectigo Domain SSL
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Cocrystal Pharma
Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics.
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
Immunovia
Immunovia is the center for translational cancer research in Lund, Sweden.
X4 Pharmaceuticals
X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.
Current Employees Featured
Christophe Blanchetot Director Discovery @ arGEN-X
Director Discovery
2016-01-01
Keith Woods Chief Operating Officer @ arGEN-X
Chief Operating Officer
2018-01-01
Hans De Haard CSO @ arGEN-X
CSO
2008-01-01
Christophe Blanchetot Research Fellow @ arGEN-X
Research Fellow
2011-03-01
Eric Castaldi CFO @ arGEN-X
CFO
Founder
Stock Details
Investors List
Burrage Capital
Burrage Capital investment in Post-IPO Equity - arGEN-X
MPM Capital
MPM Capital investment in Post-IPO Equity - arGEN-X
Dafna Capital Management
Dafna Capital Management investment in Post-IPO Equity - arGEN-X
Aquila Capital
Aquila Capital investment in Post-IPO Equity - arGEN-X
Erasmus MC Biomedical Fund
Erasmus MC Biomedical Fund investment in Series B - arGEN-X
PMV
PMV investment in Series B - arGEN-X
Omnes Capital
Omnes Capital investment in Series B - arGEN-X
Seventure Partners
Seventure Partners investment in Series B - arGEN-X
OrbiMed
OrbiMed investment in Series B - arGEN-X
Forbion Capital Partners
Forbion Capital Partners investment in Series B - arGEN-X
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-02-06 | Halozyme Therapeutics | arGEN-X investment in Post-IPO Equity - Halozyme Therapeutics | 30 M USD |
Official Site Inspections
http://www.argenx.com Semrush global rank: 467.41 K Semrush visits lastest month: 110.13 K
- Host name: 151.101.131.10
- IP address: 151.101.131.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "arGEN-X"
argenx | Homepage - Reaching Patients Through …
Argenx comes from the story of the Argonauts – we want to achieve the unthinkable together. Dare To Do More We dare you to see where argenx can take your career next. List of jobs. Pipeline. Product Candidates Our …See details»
Company Profile - argenx Annual Report 2023
On May 5, 2017, we transferred the legal ownership of all intellectual property rights of argenx SE to argenx BV, effective retroactively as of January 1, 2017. As a result, since January 1, 2017, (i) argenx BV holds all legal and economic …See details»
Careers - Dare To Do More - Argenx
If you are entrepreneurial, committed to make a difference for patients and thrive on creating solutions for some of the toughest autoimmune diseases then argenx is for you. As a global immunology biotech, we have opportunities spanning …See details»
argenx - Crunchbase Company Profile & Funding
Organization. argenx . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. argenx is a global …See details»
Ethics and Responsibility - Argenx
At argenx, we are on a journey together to achieve the unthinkable. We are all working hard to build an integrated immunology company and reach patients. And in doing so, we are …See details»
Company Profile - argenx Annual Report 2024
Apr 25, 2008 argenx Spain S.L., incorporated under the laws of Spain, having its registered office in Madrid, Spain and its address at Paseo dela Castellana 200, Planta 8a, Oficina 819, …See details»
argenx Medical
Welcome to Medical Affairs at argenx. Our mission is to continuously improve patient care by driving medical innovation, transformative evidence generation, industry unique collaboration …See details»
Organization and Operations - argenx Annual Report 2022
Risk Factors Related to argenx’s Organization and Operations Our Future Growth and Ability to Compete Depends on Retaining our Key Personnel and Recruiting Additional Qualified …See details»
argenx | Patients - Our Commitment to Patients
Each day at argenx, we are motivated to pursue a better tomorrow alongside patients. We aim to do this through partnership because we know that "together we are better". As your ally, we …See details»
argenx | Homepage - Reaching Patients Through Immunology …
At argenx, we’ve created an antibody innovation ecosystem where pioneering scientists and antibody engineers work side-by-side to accelerate the discovery of novel targets, disease …See details»
Our Story - Argenx
Get argenx news and updates right to your inbox. Subscribe. Download assets Get photos, fact sheets, illustrations and more. Download now. Join the team Dare to do more with a thriving …See details»
arGEN-X - businessabc
Feb 25, 2025 The company has strategic partnership with AbbVie S.À.R.L., Zai Lab Limited, and LEO Pharma A/S; and collaboration and license agreement with Genor Biopharma Co. Ltd, …See details»
Culture - Argenx
Get argenx news and updates right to your inbox. Subscribe. Download assets Get photos, fact sheets, illustrations and more. Download now. Join the team Dare to do more with a thriving …See details»
Company Profile - argenx Annual Report 2022
Argenx was founded on April 25, 2008 and is registered with the trade register of the Dutch Chamber of Commerce under number 24435214. Our registered office is at Laarderhoogtweg …See details»
Argenx Company Profile - Office Locations, Competitors, Revenue …
Oct 29, 2024 Argenx has 2 employees across 5 locations and $2.19 b in annual revenue in FY 2024. See insights on Argenx including office locations, competitors, revenue, financials, …See details»
Argenx Company Profile | Management and Employees List
Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel …See details»
Sustainability Strategy - argenx Annual Report 2024
Dec 31, 2024 argenx’s goal is to deliver immunology innovations to patients that are both first-in-class and best-in-class to transform the lives of people with serious autoimmune diseases. At …See details»
argenx | argenx Highlights 2025 Strategic Priorities
Jan 13, 2025 argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today reported …See details»
Careers - Argenx
If you are entrepreneurial, committed to make a difference for patients and thrive on creating solutions for some of the toughest autoimmune diseases then argenx is for you. As a global …See details»
Innovation - The Science of Collaboration - Argenx
The Immunology Innovation Program (IIP) is a core business strategy of argenx connecting the specialized insight into disease and target biology of our external scientific and academic …See details»